Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc (DNLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Denali Therapeutics Inc 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 USA

P: 650-866-8548

Description:

Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,686,947
Shares Outstanding, K 96,031
Annual Sales, $ 129,160 K
Annual Net Income, $ -36,240 K
Last Quarter Sales, $ 13,600 K
Last Quarter Net Income, $ -46,260 K
60-Month Beta 2.13
% of Insider Shareholders 21.20%
% of Institutional Shareholders 73.64%
Float, K 75,672
% Float 78.80%

Growth:

1-Year Return 16.24%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/10/20
Earnings Per Share ttm -0.71
EPS Growth vs. Prev Qtr 21.31%
EPS Growth vs. Prev Year -26.32%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

DNLI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -17.74
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -13.37
Return-on-Assets (Before Tax) -10.24
Profit Margin % -28.06
Net Margin % N/A
Debt/Equity 0.16
Price/Sales 18.03
Price/Cash Flow N/A
Price/Book 5.40
Book Value/Share 4.56
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar